kabutan

ROHTO PHARMACEUTICAL CO.,LTD., First Half Ordinary Profit Decreases by 18%, July-September Ordinary Profit Decreases by 39%

Wed Nov 13, 2024 3:30 pm JST Earnings

4527 ROHTO PHARMACEUTICAL CO.,LTD. 【J-GAAP】

Earnings Report

ROHTO PHARMACEUTICAL CO.,LTD. <4527> [TSE-P] announced its financial results after the market closed on November 13th (15:30). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending March 2025 (April to September) decreased by 18.0% from the same period last year to 18.5 billion yen. The progress rate against the 44.2 billion yen full-year plan was 42.1%, also falling below the five-year average of 48.5%.

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the October to March period (second half) is expected to grow by 29.6% from the same period last year, reaching 25.6 billion yen.

In the most recent three-month period, from July to September (2Q), the consolidated ordinary profit dropped to 6.31 billion yen, a 39.5% decrease compared to the same period last year. The operating profit margin significantly dropped from 14.5% in the same period last year to 8.5%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Sep, 2022 110,313 16,269 17,963 13,192 57.8 50.5 Nov 10, 2022 J-GAAP
Apr - Sep, 2023 127,869 20,966 22,678 16,594 72.7 53.4 Nov 10, 2023 J-GAAP
Apr - Sep, 2024 139,082 17,791 18,590 12,921 56.6 42.1 Nov 13, 2024 J-GAAP
YoY +8.8% -15.1% -18.0% -22.1% -22.1%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 Guidance ー ー ー ー － 16 Aug 7, 2024 J-GAAP
Apr - Sep, 2024 Results 139,082 17,791 18,590 12,921 56.6 16 Nov 13, 2024 J-GAAP
Revision Rate － － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2023 142,971 19,082 19,756 14,342 62.9 15 May 13, 2024 J-GAAP
Oct - Mar, 2024 Guidance 180,918 25,409 25,610 19,279 85.3 17 Nov 13, 2024 J-GAAP
YoY +26.5% +33.2% +29.6% +34.4% +35.7%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 238,664 33,959 35,568 26,377 115.6 22 May 12, 2023 J-GAAP
Mar, 2024 270,840 40,048 42,434 30,936 135.6 27 May 13, 2024 J-GAAP
Mar, 2025 Guidance 320,000 43,200 44,200 32,200 142.5 33 Aug 7, 2024 J-GAAP
YoY +18.2% +7.9% +4.2% +4.1% +5.1%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2023 66,698 9,674 10,436 7,504 32.9 14.5 Nov 10, 2023 J-GAAP
Oct - Dec, 2023 73,294 14,296 14,569 9,563 41.9 19.5 Feb 9, 2024 J-GAAP
Jan - Mar, 2024 69,677 4,786 5,187 4,779 21.0 6.9 May 13, 2024 J-GAAP
Apr - Jun, 2024 68,356 11,790 12,273 8,482 37.2 17.2 Aug 7, 2024 J-GAAP
Jul - Sep, 2024 70,726 6,001 6,317 4,439 19.5 8.5 Nov 13, 2024 J-GAAP
YoY +6.0% -38.0% -39.5% -40.8% -40.8%

Related Articles